Latest filing published 13 Aug 2019 for Aquestive Therapeutics, Inc., €3,567.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +87.5%Entry US$3.53 · Close at T+365 US$6.62
- -21.9%Entry US$9.31 · Close at T+365 US$7.27
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Theresa Wood: trading record in brief
All filings by Theresa Wood on record concern Aquestive Therapeutics, Inc. In total, 2 filings cover trades dated from 26 November 2018 to 9 August 2019.
The open-market record is one-sided, with 2 purchases worth €8,127 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2019 to date brings 1 purchase and no sales.
Most recently, on 13 August 2019, the filings show an open-market purchase worth €3,567 in Aquestive Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Theresa Wood
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$3.9943.9% of flowCommon StockSEC:0001214659-19-005184:0Canonical exit: 7 Nov 2019 (T+90)
- 500 shares@ US$10.3456.1% of flowCommon StockSEC:0001140361-18-043665:0Canonical exit: 24 Feb 2019 (T+90)
2 of 2 declarations